FDMT
#2604
4D Molecular Therapeutics, Inc. - Common Stock
14.6 7 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.61%
Monthly Change
+49.85%
6 month change
+58.75%
Year Change
+29.82%
Previous Close
14.9 1
Open
14.6 7
Low
14.6 7
High
14.6 7
Volume
93
Financials
- Market Capitalization 810.43 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.1
Price to sales ratio
5.1
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2582 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 8.10 USD | -0.98% | +1.50% | +29.81% | +175.51% | 833.51 M USD | ||
| 2596 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +20.37% | -14.66% | 820.97 M USD | ||
| 2615 |  DBVT DBV Technologies S.A. - American Depositary Shares | 13.54 USD | -6.04% | -5.18% | +0.67% | +42.98% | 801.73 M USD | ||
| 2637 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +12.52% | +265.08% | 773.16 M USD |
Frequently asked questions about 4D Molecular Therapeutics, Inc. Common Stock
What is the 4D Molecular Therapeutics, Inc. Common Stock stock price today?
The current price of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) is 14.67. Over the past 24 hours, the stock has changed by -1.61%. Follow the FDMT chart for real-time price dynamics.
What is the stock ticker of 4D Molecular Therapeutics, Inc. Common Stock?
4D Molecular Therapeutics, Inc. Common Stock trades under the ticker FDMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 4D Molecular Therapeutics, Inc. Common Stock stock going up?
FDMT has changed by -6.44% over the last week, +49.85% over the last month, and +29.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of 4D Molecular Therapeutics, Inc. Common Stock?
4D Molecular Therapeutics, Inc. Common Stock currently has a market capitalization of 810.43 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were 4D Molecular Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, 4D Molecular Therapeutics, Inc. Common Stock reported earnings of -1.04 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was 4D Molecular Therapeutics, Inc. Common Stock revenue for the last quarter?
4D Molecular Therapeutics, Inc. Common Stock reported quarterly revenue of 3.78 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was 4D Molecular Therapeutics, Inc. Common Stock net income for the last quarter?
4D Molecular Therapeutics, Inc. Common Stock reported net income of -72.94 M for the last quarter. The previous quarter showed -68.76 M, which means net income changed by -6.07%.
How many employees does 4D Molecular Therapeutics, Inc. Common Stock have?
As of the latest available data, 4D Molecular Therapeutics, Inc. Common Stock has 196 employees. Workforce size can provide additional context about the company's scale and operations.
What is 4D Molecular Therapeutics, Inc. Common Stock EBITDA?
4D Molecular Therapeutics, Inc. Common Stock EBITDA is -76.72 M, and its EBITDA margin is -2 028.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 4D Molecular Therapeutics, Inc. Common Stock stock?
You can buy 4D Molecular Therapeutics, Inc. Common Stock (FDMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 4D Molecular Therapeutics, Inc. Common Stock stock?
Investing in 4D Molecular Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FDMT chart and related analysis on metatrader.com as part of your research.